Novel Synthetic Lipopeptides as Potential Mucosal Adjuvants Enhanced SARS-CoV-2 rRBD-Induced Immune Response

As TLR2 agonists, several lipopeptides had been proved to be candidate vaccine adjuvants. In our previous study, lipopeptides mimicking N-terminal structures of the bacterial lipoproteins were also able to promote antigen-specific immune response. However, the structure-activity relationship of lipo...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Ling, Liu, Chang, Liu, Jing-Yi, Jin, Zi-Li, Jin, Zhe, Xue, Ruo-Yi, Feng, Rang, Li, Guo-Cheng, Deng, Yan, Cheng, Hao, Zou, Quan-Ming, Li, Hai-Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959576/
https://www.ncbi.nlm.nih.gov/pubmed/35356002
http://dx.doi.org/10.3389/fimmu.2022.833418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959576/
https://www.ncbi.nlm.nih.gov/pubmed/35356002
http://dx.doi.org/10.3389/fimmu.2022.833418

Ejemplares similares